Prognostic factors and predictive models in renal cell carcinoma: a contemporary review.
about
Cytoreductive surgery in the era of targeted molecular therapyFrontiers in clinical and molecular diagnostics and staging of metastatic clear cell renal cell carcinomaInhibition of endogenous hydrogen sulfide production in clear-cell renal cell carcinoma cell lines and xenografts restricts their growth, survival and angiogenic potential.Increased B4GALT1 expression associates with adverse outcome in patients with non-metastatic clear cell renal cell carcinoma.Differential expression of prognostic proteomic markers in primary tumour, venous tumour thrombus and metastatic renal cell cancer tissue and correlation with patient outcomeStage-dependent prognostic impact of molecular signatures in clear cell renal cell carcinoma.History and structures of telecommunication in pathology, focusing on open access platforms.Analyses of potential predictive markers and survival data for a response to sunitinib in patients with metastatic renal cell carcinoma.FUT11 as a potential biomarker of clear cell renal cell carcinoma progression based on meta-analysis of gene expression dataHigh CXC chemokine receptor 4 expression is an adverse prognostic factor in patients with clear-cell renal cell carcinomaClinico-pathological prognostic factors of renal cell carcinoma: A 15-year review from a single center in GreecePotential health gains for patients with metastatic renal cell carcinoma in daily clinical practice: A real-world cost-effectiveness analysis of sequential first- and second-line treatments.Genomic Analysis as the First Step toward Personalized Treatment in Renal Cell CarcinomaAnalysis and validation of tissue biomarkers for renal cell carcinoma using automated high-throughput evaluation of protein expression.Resampling phase III data to assess phase II trial designs and endpoints.Impact of miR-21, miR-126 and miR-221 as prognostic factors of clear cell renal cell carcinoma with tumor thrombus of the inferior vena cava.Management of metastatic renal cell carcinoma patients with poor-risk features: current status and future perspectives.The current status of tailor-made medicine with molecular biomarkers for patients with clear cell renal cell carcinoma.Renal cancer biomarkers: the promise of personalized careVicious cycle of TGF-β signaling in tumor progression and metastasis.WNT10A plays an oncogenic role in renal cell carcinoma by activating WNT/β-catenin pathway.Impact of age on the cancer-specific survival of patients with localized renal cell carcinoma: martingale residual and competing risks analysisIdentification of a suitable qPCR reference gene in metastatic clear cell renal cell carcinoma.Prognostic impact of urokinase-type plasminogen activator system components in clear cell renal cell carcinoma patients without distant metastasisDNA methylation biomarkers predict progression-free and overall survival of metastatic renal cell cancer (mRCC) treated with antiangiogenic therapies.Impairment of cognitive functioning during Sunitinib or Sorafenib treatment in cancer patients: a cross sectional studyExpression of IL-4 and IL-13 predicts recurrence and survival in localized clear-cell renal cell carcinoma.Chromosomal imbalances revealed in primary renal cell carcinomas by comparative genomic hybridization.Piwi-interacting RNAs as novel prognostic markers in clear cell renal cell carcinomas.Prognostic significance of ST3GAL-1 expression in patients with clear cell renal cell carcinomaHistological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomyVariation in use of targeted therapies for metastatic renal cell carcinoma: Results from a Dutch population-based registry.Expression Profiles and Clinical Significance of MicroRNAs in Papillary Renal Cell Carcinoma: A STROBE-Compliant Observational Study.Quantification of the concentration gradient of biomarkers between ovarian carcinoma interstitial fluid and blood.PinX1 serves as a potential prognostic indicator for clear cell renal cell carcinoma and inhibits its invasion and metastasis by suppressing MMP-2 via NF-κB-dependent transcription.Hyperpolarized 13C-pyruvate magnetic resonance reveals rapid lactate export in metastatic renal cell carcinomasChallenges in RCC Imaging: Renal Insufficiency, Post-Operative Surveillance, and the Role of Radiomics.Validation of the pre-treatment neutrophil-lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients.Development and validation of a prognostic model in patients with metastatic renal cell carcinoma treated with sunitinib: a European collaboration.High Level of Anaphylatoxin C5a Predicts Poor Clinical Outcome in Patients with Clear Cell Renal Cell Carcinoma.
P2860
Q26774134-C56A489F-32E5-4538-B6A8-269ABCC35FFAQ26863402-D72C20FB-9319-425F-B9B5-E5761DB59534Q27304863-A89E5411-B958-4B91-A743-F2F7EF39A6F7Q27853378-A6B8322D-844D-417E-B7B5-58C7D6FDA291Q28486028-18947C37-0056-40ED-A237-BED92904ECE0Q30317437-61D9305B-F5C4-4631-9B43-4F519265AE90Q30472194-68A5504A-3C4B-4EBF-AD71-0F42101C3C51Q30671049-4D047A15-B762-41AF-BB42-5D1CC2DAE9E2Q30711138-59232537-D90A-4D29-9DB8-F7F7DD40ADDBQ33555276-3C4D5EA2-CE98-4A42-96C9-9FD28EA5C76DQ33614217-C870B634-023F-4C58-8E6A-5DB13617639BQ33712944-A518558A-1621-4706-A6BB-276C4616C0B5Q33947929-BBE6811C-0220-48A2-A90C-1CD1F0D1DA78Q34051218-33449BC2-01AD-42D5-93D1-0D2627EB12F9Q34144413-300EB01C-3F19-4D0F-A32E-0F60A55CFE43Q34287632-ECC9C473-619D-4C23-9615-794262F4FF5EQ34351372-19A0462A-EF1A-4201-AC61-06C182FC158CQ34365135-1324F852-8DD4-4978-B94C-801B4B5298FAQ34422845-9255D125-753C-4C76-81CC-BF8624BF41ABQ34448186-1B91DF5D-19C4-421C-8C3C-5A5E34E982AAQ34456446-2BA5BDBC-8115-4CCE-84A9-374C903D91B5Q34465177-715F66F7-2B11-4A9B-891C-2EF68853EB9AQ34767097-C6C574FB-3D32-4A97-875E-3D8C17B7C0EFQ34995476-C4F65C12-0954-4010-8D6B-BF4C8E317A07Q35122019-E8D59170-A8BF-4EF5-903D-38E370CE9A75Q35128805-530B849E-6EF9-4FBA-AA99-7E04552FB3FEQ35405080-9904F876-8B21-4998-8617-91B5589D1205Q35740959-E5682E5C-B8A0-4A33-A77F-BFF426D4EA0EQ35741847-DD67284F-7DBE-4193-9994-31358D3D3A0BQ35836524-EEEA47FC-E947-4223-9108-BDB5FD966E7BQ35947018-96534A7D-C4DA-41A6-AF08-DB2D5312BE0EQ36048725-BFFCF1CF-0094-441D-A0A7-20EECB2DFB5CQ36152135-B2D5A20A-3595-48E4-BB19-5A522AE6631FQ36250701-F8457387-5D72-4A90-AD80-DBB221AA6100Q36356348-5E35625E-3A77-4FD0-BC60-AD754EEEA6FDQ36545086-B1E7E2A3-272C-4440-9E90-F9C546DE292DQ36628918-1D74FB95-BCCA-4543-A9CD-7218DE0A1732Q36663605-564A2A81-8D37-4A9D-A76A-560F66E70AE3Q37040692-7711F8C6-A733-4CF7-BA76-E43B82C61BCBQ37067601-37CF473B-FE42-4D74-85C8-833493942616
P2860
Prognostic factors and predictive models in renal cell carcinoma: a contemporary review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prognostic factors and predictive models in renal cell carcinoma: a contemporary review.
@en
Prognostic factors and predictive models in renal cell carcinoma: a contemporary review.
@nl
type
label
Prognostic factors and predictive models in renal cell carcinoma: a contemporary review.
@en
Prognostic factors and predictive models in renal cell carcinoma: a contemporary review.
@nl
prefLabel
Prognostic factors and predictive models in renal cell carcinoma: a contemporary review.
@en
Prognostic factors and predictive models in renal cell carcinoma: a contemporary review.
@nl
P2093
P1433
P1476
Prognostic factors and predictive models in renal cell carcinoma: a contemporary review.
@en
P2093
Allan J Pantuck
Christopher Cheng
Masaru Murai
Maxine Sun
Pierre I Karakiewicz
Richard Zigeuner
Shahrokh F Shariat
Stéphane Oudard
Vincenzo Ficarra
P304
P356
10.1016/J.EURURO.2011.06.041
P407
P577
2011-06-30T00:00:00Z